AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor	Arrhythmias, Cardiac, Atrial Remodeling, Cardiomegaly, Cardiotoxicity, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Consciousness Disorders, Drug-Related Side Effects and Adverse Reactions, Infarction, Necrosis, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Syncope, Unconsciousness, Ventricular Dysfunction, Ventricular Dysfunction, Left, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, heart failure, heart valve disorder, hereditary disease, injury, ischemic disease, laminopathy, myocardial infarction, myocardial ischemia, nervous system disorder, radiation injury, vascular disorder	Recruiting	Not stated	2026-06-01		NCT06699056

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peerbridge Health, Inc	3

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hackensack University Medical Center	Hackensack	United States	308
Henry Ford Hospital	Detroit	United States	326
Moses H. Cone Memorial Hospital	Greensboro	United States	5
Mount Sinai Hospital	New York	United States	7
Orange County Heart Institute	Orange	United States	1
Peerbridge Health	Pasadena	United States	1
South Heart Clinic	Weslaco	United States	1
Texas Cardiac Arrhythmia Research Foundation	Austin	United States	19